These results suggested that TR‐ZRA has a broad modulatory effect, and thus, this nanodelivery system offers new possibilities for the treatment of brain aging and other neurodegenerative diseases, including but not limited to AD. The gene discussed is TFRC; the disease is Alzheimer disease.